✨ Fisheries and Health Notices
4594 NEW ZEALAND GAZETTE, No. 183 3 NOVEMBER 2005
-
Commencement—This notice shall come into effect the
day after the date of its notification in the New Zealand
Gazette. -
Northland Scallop Fishery defined—The Northland
Scallop Fishery quota management area is the area as
defined as SCA1 in the First Schedule of the Fisheries
Act 1996. -
Total allowable catch for the Northland Scallop
Fishery increased for 2005-2006 fishing year—The
total allowable catch for the Northland Scallop Fishery
for the 2005-2006 fishing year is increased to 112 tonnes
meatweight in accordance with section 13 (7) of the
Fisheries Act 1996.\n -
Total allowable catch for the Northland Scallop
Fishery reverts—From 1 April 2006, the total allowable
catch for the Northland Scallop Fishery reverts back to
75 tonnes meatweight in accordance with section 13 (8) of
the Fisheries Act 1996.
Dated at Wellington this 31st day of October 2005.
JIM ANDERTON, Minister of Fisheries.
go7360
Health
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or
use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Primidone
Active Ingredient: Primidone 250mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Weston, Ontario, Canada
Note: This consent is valid for two years from 1 November 2005.
Product: Bicillin L-A
Active Ingredient: Benzathine benzylpenicillin tetrahydrate 450mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Wyeth Pharmaceuticals Inc, West Chester, Pennsylvania, United States of America
Note: This consent is valid for two years from 18 December 2005.
Product: Herceptin
Active Ingredient: Trastuzumab 150mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche AG, Basel, Switzerland
Note: This consent is valid for two years from 10 January 2006.
Product: Herceptin
Active Ingredient: Trastuzumab 440mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche AG, Basel, Switzerland
Genentech Inc, South San Francisco, California, United States of America
Note: This consent is valid for two years from 8 November 2005.
Product: Rapamune
Active Ingredient: Sirolimus 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Pharmaceuticals Inc, Rouses Point, New York, United States of America
Note: This consent is valid for two years from 26 June 2005.
Dated this 28th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7376
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 183
Gazette.govt.nz —
NZ Gazette 2005, No 183
✨ LLM interpretation of page content
🌾
Fisheries (Northland Scallop Total Allowable Catch) Notice 2005
(continued from previous page)
🌾 Primary Industries & Resources31 October 2005
Fisheries Act, Northland Scallop, Total Allowable Catch
- JIM ANDERTON, Minister of Fisheries
🏥 Renewal of Provisional Consent to the Distribution of New Medicines
🏥 Health & Social Welfare28 October 2005
Medicines Act, Provisional Consent, New Medicines
- DON MATHESON, Deputy Director-General, Public Health